Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Leukemia
			Lymphoma
2		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
3		Interventions listed in this trial
			aldesleukin
			cyclophosphamide
			prednisone
			therapeutic autologous lymphocytes
			vincristine
			adjuvant therapy
4		More general drug interventions related to this trial
			Alkylating Agents
			Anti-HIV Agents
			Anti-Infective Agents
			Anti-Inflammatory Agents
			Anti-Retroviral Agents
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Antineoplastic Agents, Hormonal
			Antineoplastic Agents, Phytogenic
			Antirheumatic Agents
			Antiviral Agents
			Glucocorticoids
			Hormones
			Hormones, Hormone Substitutes, and Hormone Antagonists
			Immunologic Factors
			Immunosuppressive Agents
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Myeloablative Agonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Tubulin Modulators
5		Sponsors listed in this trial
			Fred Hutchinson Cancer Research Center
			National Cancer Institute (NCI)